Prostate Nutrition and Exercise STudy (ProNEST)
NCT03173807 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL
Last updated 2017-10-06
Summary
The purpose of this study is to test the feasibility of nutrition and exercise counseling program for reducing the incidence of metabolic syndrome in prostate cancer patients on Androgen Deprivation Therapy.
Conditions
- Metabolic Syndrome
- Prostate Cancer
- Diet Modification
Interventions
- BEHAVIORAL
-
diet and exercise guidance and modifications
Review of diet, food diary, and guidance from the dietician; review of activity journal, assessment of body composition, tests for gait, balance and muscle strength, and new assignment from the exercise trainer
Sponsors & Collaborators
-
University of Pittsburgh
lead OTHER
Principal Investigators
-
Jennifer McArdle, PA-C · UPMC CancerCenter
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-08-31
- Primary Completion
- 2019-12-31
- Completion
- 2021-12-31
More Related Trials
-
Lifestyle Intervention in Patients With Metastatic Prostate Cancer
NCT05850182 ·Status: RECRUITING ·Phase: NA
-
Insulin Resistance and Androgen Deprivation Therapy
NCT04995978 ·Status: WITHDRAWN ·Phase: PHASE2
-
Nutrition and Exercise Interventions for Androgen Deprivation Therapy-Induced Obese Frailty in Elderly and Non-Elderly Survivors of Advanced Prostate Cancer
NCT03880422 ·Status: RECRUITING ·Phase: NA
-
Living Well on Androgen Deprivation Therapy
NCT02108613 ·Status: WITHDRAWN ·Phase: NA
-
Exercise Intervention Among Men With Prostate Cancer Initiating Androgen Deprivation Therapy
NCT03070145 ·Status: COMPLETED ·Phase: NA
-
Exercise Prescription Dose for Castration Resistance Prostate Cancer Patients
NCT03526562 ·Status: COMPLETED ·Phase: NA
-
Genistein Supplementation to Mitigate Cardiometabolic Dysfunction in Patients Undergoing Androgen Deprivation Therapy for Prostate Cancer
NCT02766478 ·Status: TERMINATED ·Phase: PHASE2
-
Resistance Training +/- Creatine for Metastatic Prostate Cancer Patients
NCT03987217 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
A Study on the Effects of Exercise Therapy on Signs of Prostate Cancer
NCT05751434 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Nutrition and Prostate Cancer
NCT03532308 ·Status: TERMINATED ·Phase: PHASE3
-
Exercise in Prostate Cancer
NCT06165302 ·Status: RECRUITING ·Phase: NA
-
Exercise Intervention for Pts With Metastatic Castration-Resistant Prostate Cancer Receiving Abiraterone or Enzalutamide
NCT02130947 ·Status: WITHDRAWN ·Phase: NA
-
Gene Expression in Patients With Metastatic Prostate Cancer Receiving CYP-17 Inhibition Therapy
NCT01953640 ·Status: ACTIVE_NOT_RECRUITING
-
Atorvastatin Calcium in Preventing Metabolic Syndrome in Prostate Cancer Patients Receiving Androgen-Deprivation Therapy
NCT01555632 ·Status: WITHDRAWN ·Phase: NA
-
Follow-Up Study for Men Diagnosed With Prostate Cancer Through Participation in a Prostate Specific Antigen Screening Program
NCT00035217 ·Status: COMPLETED
-
Phase I Dose-escalation Study of Fractionated 177Lu-PSMA-617 for Progressive Metastatic CRPC
NCT03042468 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Nutrition and Lifestyle Changes in Patients With Previously Untreated Stage I or Stage II Prostate Cancer
NCT00739791 ·Status: COMPLETED ·Phase: NA
-
Feasibility of Measuring Exercise's Effects on Molecular Mechanisms of Disease Progression in Prostate Cancer
NCT02481648 ·Status: UNKNOWN ·Phase: NA
-
Lycopene in Treating Patients With Metastatic Prostate Cancer
NCT00068731 ·Status: COMPLETED ·Phase: PHASE2
-
Exercise to Enhance Cardiovascular Health Among Black Prostate Cancer Patients With Androgen Deprivation Therapy
NCT05327465 ·Status: RECRUITING ·Phase: NA
-
A Phase I Study of PCUR-101 in Combination With Androgen Suppression Therapy in the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer
NCT03137758 ·Status: TERMINATED ·Phase: PHASE1
-
Docetaxel, Androgen Deprivation and Proton Therapy for High Risk Prostate Cancer
NCT01040624 ·Status: COMPLETED ·Phase: NA
-
Pioglitazone and Insulin Resistance in ADT
NCT05098327 ·Status: WITHDRAWN ·Phase: PHASE3
-
Metastasis-directed Therapy for Oligorecurrent Prostate Cancer
NCT05352178 ·Status: RECRUITING ·Phase: PHASE3
-
Men With Metastatic Castrate-Resistant Prostate Cancer Treated With Either Sipuleucel-T (Provenge®), Abiraterone Acetate (Zytiga®) or Enzalutamide (Xtandi®) Undergoing Cardiopulmonary EXercise Testing
NCT02353715 ·Status: COMPLETED